Glooko In the News
Consolidation Surge Hits Healthtech
Glooko, a leading provider of digital-health and remote-patient monitoring systems for diabetes, acquired Monarch Medical Technologies, adding an inpatient...
Read MoreFDA clears Glooko’s cloud-based insulin dosing platform
Ideating on Glooko’s existing EndoTool system, the cloud-based version is designed to support more scalable deployment across hospital settings.
FDA Grants 510(k) Clearance for Glooko’s EndoTool IV Cloud Insulin Dosing Platform
Glooko has received U.S. FDA 510(k) clearance for EndoTool IV Cloud, making it the first cloud-based, patient-specific insulin dosing platform cleared...
FDA Clears Glooko’s Cloud Platform for IV Insulin Dosing
Glooko has won FDA clearance for EndoTool IV Cloud, a cloud-based patient-specific insulin dosing platform that supports individualized insulin dosing...
Glooko wins FDA clearance for cloud-based insulin dosing platform
Glooko announced that the FDA granted 510(k) clearance for its EndoTool IV Cloud, a cloud-based, patient-specific insulin dosing platform.
FDA Clears EndoTool IV Cloud for Inpatient IV Insulin Dosing Support
The US FDA cleared the EndoTool IV Cloud, a cloud-based version of parent company Glooko’s inpatient intravenous insulin dosing decision-support platform,...
MyLife Diabetes Care, Glooko expand partnership
Glooko and MyLife Diabetes Care announced that they agreed to expand their partnership centered around diabetes management products.